Valuation: C&R Research Inc.

Market Cap 22.24B 16.07M 13.78M 12.89M 11.78M 22.23M 1.54B 22.47M 152M 59.3M 773M 60.35M 59.05M 2.56B P/E 2024
17.1x
P/E 2025 19.9x
Enterprise Value 19.57B 14.14M 12.12M 11.34M 10.37M 19.56M 1.35B 19.77M 134M 52.17M 680M 53.1M 51.95M 2.25B EV / Sales 2024
0.98x
EV / Sales 2025 0.75x
Free-Float
36.73%
Yield 2024
0.86%
Yield 2025 -
1 day-0.87%
1 week-3.97%
Current month+9.51%
1 month-1.12%
3 months-39.25%
6 months-57.00%
Current year-57.00%
1 week 1,911
Extreme 1911
2,095
1 month 1,671
Extreme 1671
2,095
Current year 1,667
Extreme 1667
4,870
1 year 1,667
Extreme 1667
5,890
3 years 1,667
Extreme 1667
11,975
5 years 1,667
Extreme 1667
13,400
10 years 1,667
Extreme 1667
13,400
Manager TitleAgeSince
Chief Executive Officer 74 2021-12-07
Director of Finance/CFO 49 -
President 56 -
Director TitleAgeSince
Director/Board Member 74 2021-12-07
Director/Board Member 62 2021-10-27
Director/Board Member 56 -
Date Insider Type Main position Quantity % Market Cap.
12/22/24 Sell 73,163 0.1290%
9/23/24 Buy 6,675 0.0118%
9/23/24 Buy 13,325 0.0236%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%-3.97%-62.24%-71.18% 16.19M
-0.74%+3.78%+3.74%+23.10% 51.61B
+1.01%-0.20%+471.68%+564.93% 44.89B
+0.16%+7.88%+36.14%+20.76% 42.77B
-0.66%+2.61%+18.59%+87.04% 42.58B
+0.88%-3.48%+17.20%+53.83% 31.82B
-0.12%+3.84%+33.73%+145.25% 17.33B
-0.53%+1.84% - - 16.63B
+0.58%+4.66%+7.17%+30.87% 14.76B
+1.15%+4.17%+84.49%+50.33% 14.09B
Average +0.09%+3.49%+67.83%+100.55% 27.65B
Weighted average by Cap. +0.10%+4.10%+100.57%+140.62%

Financials

2024 2025
Net sales 59.69B 43.14M 36.97M 34.59M 31.62M 59.67M 4.13B 60.3M 409M 159M 2.07B 162M 158M 6.86B 64.98B 46.97M 40.25M 37.65M 34.42M 64.96M 4.5B 65.65M 446M 173M 2.26B 176M 173M 7.47B
Net income 3.84B 2.77M 2.38M 2.22M 2.03M 3.84M 266M 3.88M 26.32M 10.23M 133M 10.42M 10.19M 441M 2.59B 1.87M 1.6M 1.5M 1.37M 2.58M 179M 2.61M 17.73M 6.89M 89.85M 7.02M 6.86M 297M
Net Debt -7.67B -5.55M -4.75M -4.45M -4.07M -7.67M -531M -7.75M -52.61M -20.46M -267M -20.82M -20.37M -882M -2.67B -1.93M -1.66M -1.55M -1.42M -2.67M -185M -2.7M -18.33M -7.13M -92.92M -7.26M -7.1M -307M
Logo C&R Research Inc.
C&R Research Inc is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center.
Employees
510
Date Price Change Volume
26-08-24 ₩1,935.00 -0.87% 5,694
26-08-21 ₩1,952.00 -1.46% 6,459
26-08-20 ₩1,981.00 -0.40% 4,473
26-08-19 ₩1,989.00 -0.05% 6,689
  1. Stock Market
  2. Stocks
  3. A359090 Stock